 prospect trial interferon-alpha children chronic hepat thirty-six children chronic hepat control trial recombin human interferon-alpha patient hepat viru dna level aminotransferas serum twelv children MU interferon-alpha bodi surfac area time week group children condit group II children control group iii mo therapi patient group group II hepat viru dna serum neg comparison rate respons group control signific differ eleven patient hepat viru dna serum hbeag anti-hb improv liver histolog find loss hepat viru dna liver serum alt level normal interferon-alpha children therapi find cours interferon-alpha effect serolog biochem histolog remiss diseas children chronic hepat